Michael P. Neary

Direttore Tecnico/Scientifico/R&S presso Promentis Pharmaceuticals, Inc.

Health Technology

Consumer Services

Profilo

Michael P.
Neary is currently the Director of Research & Development at Promentis Pharmaceuticals, Inc. He previously worked as a Principal at Roche Madison, Inc. Neary received his undergraduate degree from the University of Wisconsin.

Posizioni attive di Michael P. Neary

Società	Posizione	Inizio
Promentis Pharmaceuticals, Inc. Promentis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Promentis Pharmaceuticals, Inc. engages in the develop of novel compounds for the treatment of schizophrenia and other central nervous system disorders. The firm's drug development efforts are focused on the neurotransmitter glutamate and its critical role in the pathophysiology of schizophrenia and other disesses. It discovers, develops and markets new drugs for the treatment of important human diseases, focusing initially on developing a new antipsychotic drug to treat schizophrenia. The company was founded by David A. Baker and John Mantsch in 2007 and is headquartered in Milwaukee, WI.	Direttore Tecnico/Scientifico/R&S	01/01/2010

Tutte le posizioni attive di Michael P. Neary

Precedenti posizioni note di Michael P. Neary

Società	Posizione	Fine
Roche Madison, Inc. Roche Madison, Inc. Pharmaceuticals: MajorHealth Technology Roche Madison, Inc. provides gene transfer technologies to the pharmaceutical industry. The company was founded in 1995 by Jon Wolff, James Hagstrom and Vladimir Budker and is headquartered in Madison, WI.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Michael P. Neary

Formazione di Michael P. Neary

University of Wisconsin

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Michael P. Neary

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Promentis Pharmaceuticals, Inc. Promentis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Promentis Pharmaceuticals, Inc. engages in the develop of novel compounds for the treatment of schizophrenia and other central nervous system disorders. The firm's drug development efforts are focused on the neurotransmitter glutamate and its critical role in the pathophysiology of schizophrenia and other disesses. It discovers, develops and markets new drugs for the treatment of important human diseases, focusing initially on developing a new antipsychotic drug to treat schizophrenia. The company was founded by David A. Baker and John Mantsch in 2007 and is headquartered in Milwaukee, WI.	Health Technology
Roche Madison, Inc. Roche Madison, Inc. Pharmaceuticals: MajorHealth Technology Roche Madison, Inc. provides gene transfer technologies to the pharmaceutical industry. The company was founded in 1995 by Jon Wolff, James Hagstrom and Vladimir Budker and is headquartered in Madison, WI.	Health Technology